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Abstract
Background: Immediate early genes (IEGs) encode transcription factors which serve as first line response modules
to altered conditions and mediate appropriate cell responses. The immediate early response gene EGR1 is involved
in physiological adaptation of numerous different cell types. We have previously shown a role for EGR1 in
controlling processes supporting chondrogenic differentiation. We recently established a unique set of
phenotypically distinct cell lines from the human nucleus pulposus (NP). Extensive characterization showed that
these NP cellular subtypes represented progenitor-like cell types and more functionally mature cells.
Methods: To further understanding of cellular heterogeneity in the NP, we analyzed the response of these cell
subtypes to anabolic and catabolic factors. Here, we test the hypothesis that physiological responses of distinct NP
cell types are mediated by EGR1 and reflect specification of cell function using an RNA interference-based
experimental approach.
Results: We show that distinct NP cell types rapidly induce EGR1 exposure to either growth factors or inflammatory
cytokines. In addition, we show that mRNA profiles induced in response to anabolic or catabolic conditions are cell
type specific: the more mature NP cell type produced a strong and more specialized transcriptional response to
IL-1β than the NP progenitor cells and aspects of this response were controlled by EGR1.
Conclusions: Our current findings provide important substantiation of differential functionality among NP cellular
subtypes. Additionally, the data shows that early transcriptional programming initiated by EGR1 is essentially
restrained by the cells’ epigenome as it was determined during development and differentiation. These studies
begin to define functional distinctions among cells of the NP and will ultimately contribute to defining functional
phenotypes within the adult intervertebral disc.
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Background
Cell models provide valuable tools to study important as-
pects of cell and tissue biology, including development,
differentiation and physiological adaptation to changes in
the cellular environment. Such micro-environmental
changes include mitogenic or differentiation stimuli, cell-
cell and cell-extracellular matrix (ECM) contacts or
exposure to catabolic factors such as inflammatory cyto-
kines. Despite their close resemblance to cells in their na-
tive tissue environment, primary cell models often have
restricted application due to their limited proliferative
capacity, cellular heterogeneity and poor definition of ap-
propriate culturing conditions. Combined, these factors
will cause any physiological response in primary isolates
to be an average of multiple, potentially different, re-
sponses by a variety of cell types. As such immortal cell
lines provide powerful tools to explore isolated cell biology
under normal and pathological conditions.
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Cells of the nucleus pulposus (NP) and annulus fibro-
sus (AF), the two main tissues that form the structure of
the intervertebral disc (IVD), are responsible for IVD
homeostasis. The gelatinous NP mediates central ab-
sorption of mechanical forces, whereas the surrounding
fibrous AF secures the positioning of the NP and con-
nects the IVD to the adjacent endplates and vertebra [1].
Human beings will develop some degree of lower back
pain and/or degenerative disc disease (DDD) as they age
[2]. DDD is associated with aberrant IVD cell function,
reduced cellularity and concomitant loss of proteogly-
cans and tissue dehydration [3]. Although IVD cells play
an important role in DDD, to date, knowledge on the
exact nature and involvement of different NP and AF
cell types in IVD development and DDD is far from
complete. Development of the AF is closely related to
definition of somites during embryogenesis, whereas a
growing number of reports support the notion that all
mature NP cells are derived from notochordal precursor
cells [4, 5]. In humans, the presence of cells that express
Brachyury T (T) sets apart a progenitor-like notochordal
cell (NC) type. As these NC cells disappear during ado-
lescence, the human IVD differs considerably from the
IVD in other species, which appears to retain a low per-
centage of NC cells [1].
Cellular heterogeneity in the human NP is poorly under-
stood. Accumulating evidence from in vivo and in vitro
experimental observations, suggests that the mature NP
comprises multiple cellular subtypes [6–10]. Although lit-
tle is known about these NP cell subpopulations this cellu-
lar heterogeneity may reflect cellular differentiation stages.
The application of human IVD-derived cell material as a
potential source of cell lines has been limited, with few
studies reporting immortalized IVD cell models [9, 11].
Despite the restricted availability of immortal IVD cell
lines, such models can provide important experimental
tools to study essential aspects of IVD biology, ranging
from the tracking of developmental origins of the NP and
AF by marker gene expression to defining cellular targets
in DDD. A detailed understanding of ontogenic, cellular
and molecular characteristics of IVD cell populations will
be valuable to increase our understanding of the contribu-
tion of such cells to DDD, for targeted drug development,
drug testing for DDD, and ultimately for the development
of cell replacement therapies and IVD regeneration.
We recently set out to generate and characterize immor-
tal human NP and AF clonal cell lines [6, 12]. The main
aim of these studies was to determine whether cellular het-
erogeneity was reflected in the immortalized pool of NP or
AF cells. Importantly, the immortalization procedure ap-
peared to have fixed distinctive cellular phenotypes: dis-
tinctive NP and AF cellular subtypes were distinguished
based on morphological characteristics, on the basis of spe-
cific gene and/or protein expression profiles and their
response to specific culturing and/or differentiation condi-
tions [6, 12]. Hence, increased insight in composition of the
NP cell population may help define their involvement in
pivotal aspects of NP development, maintenance and
disease.
Immediate early response genes (IEG) comprise a larger
family of responder genes that provide an essential link
between the micro-environment of a cell and its physi-
ology. IEGs encode transcription factors that govern gen-
omic responses to altered demands, thereby enabling
phenotypic plasticity. Despite their well-established in-
volvement in relaying mitogenic and stress responses,
relatively little is known about the involvement of IEGs in
skeletal development and homeostasis. The Early Growth
Response gene 1 (EGR1; KROX-24; NGFI-A; TIS8; ZIF-268;
ZENK) has been functionally associated to biological as-
pects of mesodermal derivatives (adipogenesis and teno-
genesis), yet relatively little is known about its function in
the IVD [13–15]. We recently established that the IEG
EGR1 mediates early chondrogenic responses of ATDC5
cells upon exposure to differentiation conditions in vitro
[16]. In addition, EGR1 has been associated with acute in-
flammatory and regenerative responses [17–22]. Thus
EGR1 may fulfill a number of crucial tasks at the cross
roads of physiological, inflammatory and regenerative re-
sponses in the IVD.
We here outline a study that begins to examine the in-
volvement of EGR1 in cell type specific responses of dis-
tinct NP subtypes to anabolic and catabolic stimuli. By
ablating EGR1 function using RNA interference, we find
that EGR1 mediates functionally distinct responses in
these NP cellular subtypes. The impact of these findings
on understanding NP cellular heterogeneity is discussed.
Methods
Intervertebral disc cells, cell culture and immortalization
The generation of immortal non-degenerate healthy disc
cells has been described elsewhere [6]. Immortalized NP
cells were cultured in maintenance medium (DMEM-F12/
Glutamax (Gibco), 10 % fetal calf serum (FCS; Biowhit-
taker, cat no DE14-801 F), 1 % penicillin/streptomycin
(Gibco), 1 % non-essential amino acids (NEAA; (Gibco)).
Cells were maintained by 1:4 splits (1 passage equals 2
population doublings) seeded at a density of 30,000 cells/
cm2. Unless stated otherwise, representative AF (AF-123)
and NP (NP-nR105; NP-R115) clones are utilized for ex-
perimentation in this study. Disc material was obtained as
surplus material from correction surgery (Medical Ethical
Review Committee approval 08-4-021) [6].
Growth factors
Cells were seeded in monolayer (8000 cells/cm2) in basal
medium. At day 2, medium was aspirated and cells were
washed twice with PBS. Cells were cultured (3 independent
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experiments) for 2 days in Differentiation Medium
(DMEM/F12 + 1 % Pen/Strep + 1 % NEAA+ 1 % ITS + 1 %
ascorbate) containing: no growth factor (control), TGFβ3
(10 ng/ml, Life technologies), GDF6 (100 ng/ml, Pepro-
tech), CTGF (100 ng/ml, Peprotech), Il-1β (10 ng/ml,
Peprotech) and TNFα (50 ng/ml, Peprotech).
RNA-interference based EGR1 knock-down
The sense siRNA sequence for human EGR1 was 5′-
ACGACAGCAGUCCCAUUUATT-3′ and the anti-sense
sequence was 5′-UAAAUGGGACUGCUGUCGUTT-3′. A
scrambled siRNA-duplex was used as control; both se-
quences were designed using algorithms provided by the
vendor (Eurogentec). IVD cell lines were seeded at 20,000
cells/cm2 and transfection with siRNAs was performed
using ICAfectin 442 (Eurogentec) according to manufac-
turers’ instructions. Procedures were essentially as de-
scribed before [16, 23]. Cells were cultured for 16 h
following siRNA transfection before stimulations were per-
formed. EGR1 siRNA concentration was optimized at 30
nM in parallel in murine and human cell lines (Additional
file 1: Figure S1A, B). Sustained EGR1 knock-down at 16 +
48 h, was verified in ITS-treated NP cells (Additional file 1:
Figure S1C).
RNA isolation and quantitative real time PCR
For RNA isolation, cells were disrupted in Trizol (Invi-
trogen). RNA isolation, RNA quantification (UV)-spec-
trometry (Nanodrop, Thermo Scientific), and cDNA
synthesis were performed as described before [20]. Real-
time quantitative PCR (RT-qPCR) was performed using
Mesagreen qPCR master mix plus for SYBR® Green
(Eurogentec). Validated primer sets used are depicted in
Table 1. An Applied Biosystems ABI PRISM 7700
Sequence Detection System was used for amplification:
initial denaturation 95 °C for 10 min, followed by 40 cy-
cles of DNA amplification. Data were analyzed using the
standard curve method and normalized to Cyclophillin B
(Cyclo).
Protein extraction and immunoblotting
Protein extraction and immunoblotting were per-
formed and analyzed as described previously with
minor adjustments [21]. For extraction, cells were
lysed in RIPA buffer (50 mM Tris pH 8.0, 150 mM
NaCl, 0.1 % SDS, 5 mM EDTA, 0.5 % w/v Sodium
Deoxycholate, and 1 % NP-40) supplemented with pro-
tease and phosphatase inhibitor (Roche). Lysates were
sonicated on ice using the Soniprep 150 MSE at ampli-
tude 10 for 14 cycles (1 s on/1 s off ). Insoluble material
was removed by centrifugation (10 min, 16000 × g, 4 °C).
Protein concentration was determined using a BCA pro-
tein assay kit (Pierce/Thermo Fisher Scientific). Proteins
samples were separated by SDS-PAGE and immobilized
on Nitrocellulose membranes. Membranes were blocked
(1 h, 5 % non-fat dry milk powder (Campina), ambient
temp), and incubated with primary antibodies (overnight,
4 °C). Antisera: mouse monoclonal EGR1 (Abcam
55160), rabbit polyclonal β-Actin (C4, 691001; MP
Biomedicals), Secondary antisera: rat anti-mouse
(P0260; DAKO, Glostrup, Denmark) and donkey anti-
rabbit (711035–152; Jackson Lab, Bar Harbor, ME,
USA). Signals were detected using enhanced chemolu-
minescence (Pierce).
Table 1 rtPCR primer sets for gene expression measurements
Symbol Forward primer Reverse primer
ADAMTS4 GGTCATGTCTTCAACATGCTCC AGGATCCACATGAGCCATCAC
COL1A1 TGGAGAGTACTGGATTGACCCC TGCAGAAGACTTTGATGGCATC
COL2A1 TGGGTGTTCTATTTATTTATTGTCTTCCT GCGTTGGACTCACACCAGTTAGT
COX2 ACCAACATGATGTTTGCATTCTTT GGTCCCCGCTTAAGATCTGTCT
EGR1 TGACCGCAGAGTCTTTTCCT TGGGTTGGTCATGCTCACTA
KRT19 GCAGTCACAGCTGAGCATGAA TCCGTTTCTGCCAGTGTGTCT
MMP3 TGATGAACAATGGACAAAGGATACA TTTCATGAGCAGCAACGAGAA
SOX9 AGTACCCGCACCTGCACAAC CGCTTCTCGCTCTCGTTCAG
T CCACCTGCAAATCCTCATCCT TTGGAGAATTGTTCCGATGAG
TNFα TCAATCGGCCCGACTATCTC CAGGGCAATGATCCCAAAGT
VCAN TCCCTCACTGTGGTCAAG GTGTGTACCTGCTGGTTG
βACT CCTGGCACCCAGCACAAT GCCGATCCACACGGAGTACT
CYCLO CCTGCTTCCACCGGATCAT CGTTGTGGCGCGTAAAGTC
EIF2B1 TGTCAGGTAAGAAAATGGCCAAA TGTAGCCGACAGCAGCATCT
MRPL19 CGCCGAAACCGGTCATC TCCCCTTCGAGGAATGAATTC
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Immunohistochemistry
Research involving human material was performed in ac-
cordance with the Declaration of Helsinki. Human IVD
tissue for histology was obtained from a 63 years old de-
ceased (non-heart beating) donor. Approval for all ex-
perimental sections of the current study and informed
consent for publication of patient details and accom-
panying images in this manuscript was obtained as an
integral part of the MUMC-Medical Ethical Review
Committee (METC approval 08-4-021; July 11, 2012);
the approval is held by the authors (LWvR) and is avail-
able for review by the Editor-in-Chief. Two lumbar IVDs
L1/2 (without overt signs of degeneration; healthy) and
L4/L5 (clearly degenerated) were dissected by an ortho-
pedic surgeon. Tissue was isolated, fixed in formalin and
decalcified in 0.5 M EDTA pH 7.8 for two weeks. EDTA
was refreshed every two days. Tissues were dehydrated
and embedded in paraffin and five micrometer section
were cut and positioned on Superfrost Plus slides. For im-
munohistochemical analysis, sections were deparaffinized
and rehydrated using standard protocols. Antigen retrieval
was performed in hot citrate buffer (1.8 mM citric acid
and 8.2 mM tri-sodium citrate), endogenous peroxidase
activity was inactivated by Peroxidase-Blocking solution
(Dako, REAL) and samples were blocked with 10 % nor-
mal sheep serum. Rabbit polyclonal anti-Egr-1 (Santa
Cruz Biotechnology) was incubated overnight at 4 °C in
1:200 concentration (primary antibody was not used for
negative control sections). Unbound antibodies were
removed by washing in PBS with 0.1 % Tween. Bound
primary antibodies were detected with HRP-labelled anti-
rabbit secondary antibodies (EnVision + System-HRP la-
belled Polymers; Dako) by incubation for 30 min at room
temperature. For detection, DAB chromogen substrate
(Dako) was used. Stained sections were counterstained
with Mayor’s Hematoxylin (Dako) and subsequently dehy-
drated and mounted in Histomount (Thermo Shandon)
for microscopic analysis.
Statistics
Statistical significance (p < 0.05) was determined by two-
tailed Student’s t-test. To test for normal distribution of
input data, D’Agostino–Pearson omnibus normality tests
were performed. All quantitative data sets presented
passed the normality tests. Gene expression analyses
show mean and standard deviation (as indicated); indi-
cated p-values in figures represent the comparison be-
tween AF and NP for all donors combined or between
clonal subtypes (NP-R vs NP-nR).
Results
Differentiation induces EGR1 in IVD cells
A detailed description of the NP cellular subtypes used
in the current study is published elsewhere [6]. We have
previously established that chondrogenic ATDC5 cells
strongly induce EGR1 mRNA and protein expression in
response to chondrogenic differentiation stimuli [16]. To
investigate whether IVD cells activate EGR1 expression
in response to changes in their environment, we initially
subjected immortal AF and NP cell lines to previously
defined chondrogenic differentiation conditions [16].
Typically, IEG expression in most cell types is low or ab-
sent under basal conditions and, upon exposure to dif-
ferentiation conditions, increases within hours at the
mRNA and protein levels. Basal EGR1 mRNA expression
was approximately 2–4 fold higher in immortal AF cells
than in two phenotypically distinct NP cell types of
which the NP-R cell type showed the lowest EGR1
mRNA levels (Fig. 1a). Exposure of these IVD cell types
to chondrogenic differentiation conditions resulted in a
robust EGR1 mRNA induction (±6 fold) at 2 h post-
induction in NP-R cells (Fig. 1b; upper panel); the max-
imum response of NP-nR cells did not reach twofold,
whereas AF cells did not show any induction of EGR1 at
the 2 h time point (Fig. 1b, upper panel). Valproic acid
(VPA), a known inducer of IEGs [24, 25], was used in a
parallel experiment as an intended positive control. VPA
exposure resulted in a pronounced upregulation of
EGR1 mRNA, although, surprisingly, exclusively in NP-
R cells; as with ITS, no EGR1 mRNA induction was de-
tected in NP-nR and AF cells (Fig. 1b, lower panel). The
twofold increase of EGR1 mRNA at 8 h post-induction
in NP-nR cells was significant, but did not qualify as an
IEG response.
We next examined EGR1 induction at the protein level.
EGR1 protein was detectable in vitro at relatively low
levels in all three IVD cell types, and was rapidly induced
within 2 h after stimulation with chondrogenic differenti-
ation medium in all cells (Fig. 1c). Despite the poor correl-
ation of basal mRNA and protein levels in these
respective cell lines under control conditions, mRNA (cf.
Fig. 1b) and protein levels upon stimulation with ITS were
consistently highest in the NP-R (responder) clone. This
data suggests that upregulation of EGR1 protein in IVD
cells is accompanied by an induction of EGR1 mRNA
preferentially in NP-R cells. Given that AF cells did not re-
spond, further analysis did not include these cells.
Distinct physiological responses in specialized NP cellular
subpopulations
In a recent report, we speculated that the distinct immortal
NP subtypes differ in differentiation/maturation status [6].
This previous data suggested that NP-R cells represent a
more progenitor–like phenotype and that NP-nR are more
mature, differentiated cells, as they do not produce the ro-
bust SOX9 response that NP-R cells show upon exposure
to differentiation conditions. In line with this idea, we have
previously shown that chondrogenic differentiation of
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ATDC5 cells is critically dependent on EGR1 [16]. Based
on these findings we speculated that the distinct NP cellular
subtypes may be differentially sensitive to specific physio-
logical stimuli. In line with the above observations, we pre-
dicted that NP-R would respond more robustly to
differentiation stimuli, whereas NP-nR may be more sensi-
tive to degenerative stimuli. To this end NP-nR and NP-R
cells were subjected to anabolic (i.e. growth factors) or cata-
bolic conditions (i.e. inflammatory cytokines), representing
potential regenerative or degenerative stimuli, respectively.
Transcriptional regulation of a number of marker genes
was measured in response to differentiation conditions,
among which: KRT19, T (Keratin 19 and Brachyury T),
SOX9 (SRY box-9), COL2A1, COL1A1 (type 2 and 1 alpha
Collagens) and VCAN (Versican), from here on referred to
as IVD marker genes. In addition, expression of a number
of catabolic markers, including MMP3 (Matrix Metallopro-
teinase 3) and ADAMTS4 (A Disintegrin and Metallopro-
teinase with Thrombospondin motifs 4,5) was determined.
The biological responses to anabolic or catabolic stimuli
showed remarkable differences between NP-R and nR sub-
types: overall anabolic conditions (growth factor stimula-
tion) induced expression of the IVD markers SOX9,
COL2A1, COL1A1, VCAN, KRT19 and T in NP-R cells
(Fig. 2a). Conversely, exposure to different growth factors
produced an overall transcriptionally repressive response of
IVD marker gene expression in NP-nR cells. This overall
effect on transcription of these IVD markers was clearly less
unidirectional in NP-R cells. The only conspicuous excep-
tion was TGFβ3-induced COL1A1 and COL2A1 induction
in the NP-nR subtype. NP-nR cells showed a massive in-
duction of MMP3 in response to IL-1β or TNFα (±1000
fold or 100 fold, respectively), whereas this response was
less pronounced in the NP-R clones (±10–100 fold less).
The ADAMTS4 marker was expressed at similar levels in
both NP subtypes in response to IL-1β and was slightly up
in the TNFα NP-R cells. This data suggests that, phenotyp-
ically distinct NP-R and NP-nR cells also differ in terms of
responses to anabolic and catabolic conditions.
EGR1-dependent responses in NP cellular subtypes
EGR1 has been reported to mediate transcriptional re-
sponses to inflammatory cytokines including IL-β [18, 19,
26, 27]. We therefore investigated the EGR1-dependence of
the catabolic responses to IL-1β, as this cytokine induced
clear differences in gene response profiles between NP-R
and NP-nR cells. We first examined the EGR1 protein in-
duction in response to IL-1β stimulation in more detail.
NP-R and NP-nR cells were exposed to IL-1β for 2 h, and
EGR1-induction was compared in whole cell extracts;
maintenance medium, differentiation medium or VPA ex-
posed cell extracts (2 h) were taken as reference conditions.
As before, NP cells induced EGR1 protein in response to
differentiation conditions. Both NP-nR and NP-R cells
Fig. 1 Induction of EGR1 expression in IVD cell lines. a Basal expression of EGR1 mRNA in representative clones (AF-123, NP-nR 105 and NP-R 115).
Gene expression was normalized to Cyclophillin B and is presented relative to the NP-R clone. b Insulin, Transferrin and selenite (ITS; 10 μg/ml insulin,
10 μg/ml transferrin and 3 × 10−8M sodium selenite) and Valproic acid (0.3 mM) were used to stimulate IVD cell lines for 0, 2, 4 and 8 h. Gene expression of
EGR1 was normalized to Cyclophillin B and is presented relative to the t = 0 time point. Bars represent a biological triplicate. c Protein expression of EGR1
under basal conditions and in response to stimulation with chondrogenic media for two hours. AF, NP-nR and NP-R samples were run on the same gel to
allow direct comparison. The indication (t+) points to a long apposition time. Βeta Actin (βACT) was used as loading control; asterisks indicate significantly
different expression level; p< 0.05
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produced an obvious EGR1 induction in response to either
10 or 100 ng/mL IL-1β (Fig. 2b). We evaluated IL-1β-
induced EGR1 response in multiple independent NP-nR
and NP-R clones: all clones showed a robust induction of
EGR1 protein upon 2 h of IL-1β treatment (Fig. 2c). Com-
bined, this data shows that both anabolic and catabolic con-
ditions induce an immediate early response in IVD cell
types. Combined, our previous observations [6] and the
data presented thus far, shows that although EGR1 is in-
duced in both NP cell subtypes by differentiation factors
and inflammatory cytokines, their transcriptomic responses
are dissimilar.
To further investigate a potential involvement of EGR1 in
the transcriptomic response to inflammatory cytokines like
IL-1β, an siRNA duplex was designed with the aim to re-
duce cellular EGR1 mRNA and protein levels; a robust
knock-down was obtained at EGR1 siRNA concentrations
of 30 and 100 nM (Additional file 1: Figure S1A), which
was specific for EGR1 as it had no effect on EGR2 and
EGR3 mRNA levels (Additional file 1: Figure S1B). NP cells
were transiently transfected with either 30 nM siRNA tar-
geting human EGR1 (siEGR1) or a scrambled control
siRNA (siCTRL). Cells were treated with IL-1β 16 h
following transfection, and samples were taken for expres-
sion analysis at 2 and 48 h post-treatment. To verify knock-
down throughout the duration of the 2 day induction ex-
periment, EGR1 protein levels were initially compared in
siCTRL or siEGR1 transfected cells at 0, 2 and 48 h post-
ITS treatment; this analysis showed a robust and sustained
reduction of EGR1 protein at 2 and 48 h post-treatment
(Additional file 1: Figure S1C). Consistent with the transi-
ent nature of IEG induction, the EGR1 protein level was
markedly increased at 2 h after IL-1β exposure and had
returned to starting (t = 0) levels at 48 h (Fig. 3a). Transfec-
tion of NP-R or NP-nR cells with the siEGR1 successfully
diminished EGR1 induction at the protein level 2 h into IL-
1β treatment, to nearly undetectable levels (Fig. 3a). At
48 h of IL-1β treatment, EGR1 was neither detectable in
the siCTRL nor in the siEGR1-transfected cells. Thus, the
siRNA duplex successfully prevented ERG1 induction in re-
sponse to IL-1β in both NP-R and NP-nR cells. Moreover,
the absence of EGR1 protein at 48 h in the siEGR1-condi-
tion suggested that the siRNA-mediated targeting strategy
did not delay EGR1-induction.
We then examined expression of a number of genes
which are known to be induced by inflammatory cytokines
Fig. 2 Cytokines induce catabolic response in the mature NP subclones. a Heatmap representation of gene expression changes in distinct NP
subclones. NP cell clones NP-nR 105 and NP-R 124 were stimulated for two days with anabolic factors TGFβ3 (10 ng/ml), GDF6 (100 ng/ml), CTGF
(100 ng/ml) or catabolic factors IL-1β (10 ng/ml) or TNFα (50 ng/ml). mRNA levels for the following genes was determined: KRT19, T, COL2A1,
SOX9, VCAN, COL1A1, MMP3 and ADAMTS4. Gene expression was normalized to the average of EIF2B1 and MRPL19 expressions. Fold induction
was calculated by comparison to untreated cells at day 2 and is represented in a heatmap; n.d.: not determined. Asterisks indicate significantly different
expression level; p < 0.05. b Protein expression of EGR1 in response to maintenance medium (med), differentiation medium (diff), IL-1β (10 and
100 ng/ml) or Valproic acid (0.3 and 1 mM). NP-nR 105 and NP-R 115 samples were run on the same gel to allow direct comparison. The indication
(t+) points to relatively long apposition times. Β Actin was used as loading control. c Three NP-nR and three NP-R clones were either left undisturbed
(con), exposed to a change of maintenance medium (med) or medium supplemented with IL-1β (10 ng/ml) for two hours. Non-stimulated cells at
time point t = 0 were used as control (con). Βeta Actin (βACT) was used as loading control
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and for which biological relevance in intervertebral disc
degeneration had been shown before [28]. These genes in-
cluded: COX2, TNFα, MMP3 and ADAMTS4. Basal ex-
pression measurements in NP-R and NP-nR clones
revealed significant differences for all genes: NP-nR cells
showed higher basal expression levels for most markers,
MMP3 excepted (Fig. 3b). We have previously shown that
chondrogenesis is dependent on intrinsic NF-κB signaling
also used by inflammatory cells [23]. In addition, we
showed a direct involvement of COX-2 in in vitro and in
vivo models for chondrogenesis [29]. We next asked
whether expression of COX2, TNFα, MMP3 and/or
ADAMTS4 was regulated in response to IL-1β, and
whether their regulation involved EGR1; the latter was
tested by comparing cells expression siRNA against EGR1
mRNA (siEGR1) to cells expressing siCTRL (control). The
absence or presence of potential EGR family-consensus
binding sites in the promoters of the corresponding genes
was assessed via www.genomatix.de (Fig. 3c). COX-2,
TNFα and MMP3 carried potential EGR1 binding sites,
whereas ADAMTS4 did not. COX-2 was neither induced
at t = 2 nor t = 48 h in NP cells, independent of subtype
(Fig. 4a). This continued repression of COX-2 expression
appeared to be dependent on EGR1 throughout our ex-
perimental setting, as COX-2 was massively induced at
48 h of IL-1β treatment in NP-nR cells (±60.000 fold) and
in NP-R cells (±40.000 fold) that lack EGR1.
NP-nR cells initiated a significantly higher TNFα tran-
scription (±3000–4000 fold versus <100 fold in NP-R
cells) in response to IL-1β (Fig. 4b). As for COX2, TNFα
expression was negatively controlled by EGR1, as EGR1
knock-down released TNFα mRNA synthesis in both NP
cell types at 2 h of IL-1β treatment, this difference was
significant from that of siCTRL cells. TNFα induction in
siEGR1 NP-R cells did not approach the high levels ob-
served in NP-nR cells (±7000 fold versus ±1200 fold).
TNFα expression appeared to be tightly controlled by
EGR1 in the early response phase, as expression ceased
at 48 h and appeared no longer dependent on EGR1.
Basal MMP3 gene expression was increased in NP cells
Fig. 3 Confirmation loss of EGR1 function. a NP-nR and NP-R clones were transfected with 30 nM siRNAs targeting EGR1 (E) or control (C) siRNA.
Sixteen hours after transfection cells were harvested (time point t = 0) and stimulated with IL-1β for 2 and 48 h. Immunoblotting for EGR1 reveals
efficient knock-down of EGR1 at two hours post stimulation in both cell lines. Βeta Actin (βACT) was used as loading control. b Basal expression
of COX2, TNFα, MMP3, and ADAMTS4 genes implicated in disc degeneration at t0. Gene expression was normalized to Cyclophillin B; asterisks indicate
significantly different expression level; p < 0.05. c In silico representation of the promotor region of genes implicated in disc degeneration (Genomatix
software; http://www.genomatix.de). Putative transcription factor (TF) binding sites for EGR family members are depicted by yellow boxes; high-
probability EGR binding sites are indicated by black/bold print arrow heads, low-probability binding sites by light grey/normal print. Black arrows
indicate the transcription start site
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transfected with EGR1 siRNA (Fig. 4c). IL-1β treatment
significantly induced MMP3 expression at 2 h in both
cell types. In analogy to the earlier observed more robust
induction of MMP3 in NP-nR versus NP-R cells (cf.
Fig. 2a), we found that MMP3 followed a similar trend
in this experimental setting: IL-1β induced MMP3
mRNA at higher levels in NP-nR siCTRL cells than in
NP-R cells at 48 h. Relevantly, in the absence of EGR1
MMP3 expression was strongly induced at 48 h in NP-R
clones. Thus, EGR1 is required to repress inflammatory
MMP3 expression stimulation in NP-R clones. Finally,
although IL-1β stimulation induced ADAMTS4 expres-
sion at 48 h in both cell-types, expression levels at 48 h
were significantly higher in NP-nR clones, compared to
NP-R clones (Fig. 4d). The absence of any effect of
EGR1-knock-down on ADAMTS4 mRNA levels in
response to IL-1β, suggests that ERG1 does not directly
regulate ADAMTS4 expression levels and is congruent
with the absence of EGR1 binding sites in its promoter.
In summary, the data presented here corroborate the
earlier observed differences in gene expression between
NP-R and NP-nR clones in response to catabolic stimuli.
EGR1 appeared to predominantly act repressive on IL-
1β-induced gene expression. For COX2 and MMP3, this
was a late effect, suggesting the involvement of add-
itional, secondary transcriptional factor and/or signaling
networks in succession to the initial transient EGR1 re-
sponse, whereas TNFα induction was repressed at an
early response time point, specifically in NP-R.
Thus far the above data show that differentiated/ma-
ture NP-nR cells are more responsive to catabolic stim-
uli than the relatively undifferentiated/progenitor-like
Fig. 4 EGR1 controls inflammatory responses in IVD cell clones. Induction of COX2 (a) TNFα (b) MMP3 (c) and ADAMTS4 (d) expression measured
by qPCR. Sixteen hours after siRNA transfection cells were harvested (time point t = 0) and stimulated with IL-1β for 2 and 48 h. Induced mRNA
levels are expressed relative (FC) to siCTRL, t = 0, for each cell type. Double asterisks (**) indicate significantly different expression levels between
siCTRL and siEGR1 measurements at the indicated time points (p < 0.05); single asterisks (*) indicate significance (p < 0.05) compared to time point
t = 0 of that series (siCTRL or siEGR1)
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NP-R cells, and that aspects of both early and main-
tained gene expression in response to IL-1β are con-
trolled by EGR1. Based on these findings, we speculated
that NP cells expressing EGR1 should be detectable in
histological sections of degenerate human intervertebral
disc material. Indeed, compared to healthy control section,
in which approximately ±5 % of cells in the NP showed
EGR1 expression, one in three NP cells in degenerate IVD
tissue displayed EGR1-positivity (Fig. 5a, b). Taken to-
gether, the data presented support the idea that EGR1 is
an important biological response factor in NP cells, and
that EGR1 expression is increased under degenerate con-
ditions in the human NP.
Discussion
We here examined a potential role for the immediate early
response gene EGR1 in various physiological responses of
phenotypically distinct immortalized NP cell types. Our
combined data shows that the immortalized NP cellular
subtypes respond differentially to anabolic and catabolic
stimuli. We also provide evidence that the immediate early
response gene product EGR1 is differentially involved in
cell type-specific responses to IL-1β in immortalized NP-
cellular subtypes in vitro. The data presented in this paper
thus supports our previous findings that the NP harbors
multiple functionally specialized cell types [6].
Distinct biological functions for NP cell types
Despite the realization that cells in the NP are crucially
involved in IVD homeostasis and pathology, little is
known about the nature and functionality of such NP
cell subpopulations. Several novel lines of evidence sup-
port the notion that the NP contains functionally dis-
tinct cell types. Recent studies have demonstrated that
the NP harbors immature cells with somatic stem cell-
like properties [8–10]. We previously reported on a
unique experimental immortalization approach to ad-
dress the issue of NP cellular heterogeneity [6]. We were
able to show that multiple phenotypically distinct NP
cell types could be immortalized and clonally expanded.
The fact that these distinct cellular subpopulations could
be isolated from independent donors provided robust
and crucial confirmation for the heterogeneous nature
of the human NP cell population. Cellular heterogeneity
in the NP may reflect different stages of proliferation,
differentiation and maturation. Our data thus far sug-
gested that NP-R (responder) clones represented a more
immature cell type that harbors an intrinsic capacity to
respond to chondrogenic differentiation stimuli. In
addition this subpopulation spontaneously formed
spheroid structures in (pseudo) 3D cultures [6]. NP-nR
(non-responder clones), in contrast, did not induce pre-
dicted key developmental control (e.g. SOX9) or lineage
marker genes (e.g. CA12, FOXF1, COMP) when exposed
to chondrogenic conditions and its relatively high
membrane-associated CD24 expression suggested that
these specific characteristics reflected an ontogenically
more advanced stage. To begin to understand the poten-
tial biological relevance of these specific NP cell pheno-
types, we compared anabolic and catabolic responses of
NP-R and NP-nR cells. Our current data show that
whereas the NP-R cell response to growth and differenti-
ation factors is substantially more robust than that of
NP-nR cells, NP-nR cells, in contrast, appeared to pro-
duce a more specialized catabolic response than NP-R
cells. Although both cell types display EGR1 induction
upon treatment with inflammatory cytokines, the differ-
ential transcriptomic response argues that, although the
Fig. 5 EGR1 expression is increased in degenerate NP cells. a Immunodetection of EGR1-positive cells in healthy control NP tissue (L1/L2 IVD of a
63 years old donor; left panel) and in degenerate NP tissue (L4/L5 IVD of the same donor middle panel); right panel: staining control on degenerate
NP section: primary antiserum detecting EGR1 was left out. b Quantification of EGR+ cell numbers in healthy or degenerate NP tissue. Cell numbers
are depicted as percentage of total cell number scored (total cell counts: 121 for healthy tissue and 218 for degenerate tissue)
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NFκB signaling network in both cell types is operational,
the NP-nR may possess a more mature downstream sig-
naling network enabling an EGR1-dependent catabolic
response. One striking example thereof is the substan-
tially higher IL-1β-induced MMP3 mRNA level in NP-
nR cells compared to NP-R cells. These findings may be
relevant in the context of IVD degeneration: indeed
MMPs are involved in DDD [30]. Based on these results
it is tempting to speculate that different IVD cell types
may have differential contributions to IVD homeostasis
and pathology: specific cells maintain homeostasis and
harbor potential regenerative capacity, whereas function-
ally distinct cells may have acquired the ability to respond
to inflammatory conditions. CD24-positive NP-nR cells
may be sufficiently mature/specialized to partake in cata-
bolic responses to tissue damage, whereas this response
would not be beneficial for precursor NP-R cells. Con-
versely, relatively immature cells would aid in tissue repair,
most likely triggered by and/or in response to signals gen-
erated by mature cells. In this respect it is interesting to
note that IL-1β and TNFα induced a more anabolic profile
in the less mature NP-R cells compared to the NP-nR cells
(cf. Fig. 2a).
EGR1 regulates NP cell type-specific responses
Understanding the specific immediate early responses of
distinct cell types provides insight into genetic and epi-
genetic wiring of a given cell system. Immediate early re-
sponse genes (IEG) mediate signaling between the
cellular micro-environment and the nucleus. The IEG
response is typically transient and serves to control sec-
ondary transcriptional responses by acting as facilitators
or repressors of gene expression, in conjunction with
other transcriptional regulatory factors [31–36]; this en-
ables cells to mount a quick and physiologically relevant
response to changed conditions. Such responses may be
anabolic, e.g. during differentiation and development or
tissue repair, or catabolic, e.g. during inflammation. We
reported before that EGR1 fulfills a crucial early role in
preparing ATDC5 cells for replicative amplification and
transcriptome remodeling that accompany chondrogenic
differentiation [16]. Here we provide evidence that in
functionally distinct NP cell types, EGR1 mediates spe-
cialized cellular responses to either growth factor stimu-
lation or inflammatory cytokines. The higher induction
of EGR1 in NP-R cells may reflect an intrinsic ability to
respond more robustly to differentiation conditions than
a NP-nR clone [6]. The ability of cells to generate a
physiologically appropriate response is dictated by its
epigenetic constitution: as a result of lineage commit-
ment and differentiation cells have become epigeneti-
cally restricted to function within a given lineage.
Although IEGs play crucial roles in helping cells respond
to, for instance, differentiation factors, increasing
experimental evidence suggests that their main task is to
augment rather than initiate gene transcriptional activity
[37, 38]. This ability is at least in part due to their re-
cruitment of Histone Acetyl Transferase (HAT) activity
to their transcriptional target sites [39]. Likewise we
found that early global histone acetylation failed in
EGR1-deficient chondrogenic cells [16]. Moreover, we
showed that, despite the presence of consensus EGR1
binding sites, Polycomb-dependent, epigenetically repres-
sive Histone H3 lysine 27 trimethyl (H3K27me3) marking
prevented promoter access of EGR1 [16]. We propose that
restrictive epigenetic boundaries dictate the cell-specific
transcriptomic responses in NP-R cells (more anabolic)
versus NP-nR cells (more catabolic). In differentiating
ATDC5 cells we were able to show that expression of cer-
tain lineage-specific genes (SOX6, AGC) was attained
through loss of repressive H3K27me3 marks [16]. It is
conceivable that similar epigenetic programming has oc-
curred during maturation of NP-R to NP-nR cells. Al-
though VPA was merely used as a positive response
control in the current study, it is interesting to note that
NP-R and NP-nR cells also responded differentially to
VPA. VPA is known to suppress IEG responses [24, 25]. It
is conceivable that the observed differences relate to a
relative insensitivity of NP-R cells to VPA (i.e. epigen-
otype). Involvement of restricted epigenomic vulnerability
to VPA may be corroborated by studies that show VPA
has teratogenic effects in certain species [40, 41] and dur-
ing defined time windows during embryogenesis [42].
Proteins of the matrix metalloproteinase (MMP) family
are involved in the breakdown of extracellular matrix in
normal physiological processes, such as embryonic devel-
opment, reproduction, and tissue remodeling, as well as in
disease processes, such as arthritis and metastasis [43–45].
EGR1 was found to mediate TNFα-induced MMP9 ex-
pression in various cell types [18]. Our data are in line
with an early role for TNFα in the catabolic response of
NP-nR cells [28], as it is rapidly and exclusively induced
by IL-1β in NP-nR cells. Interestingly, EGR1 appears to
restrain TNFα expression rather than to augment it. In-
deed, EGR1 is known to positively and negatively affect
gene expression, through partnerships with transcriptional
co-activators or co-repressors [26, 31–33].
Interestingly, both NP cell types do not induce COX2
mRNA in response to IL-1β; EGR1 clearly functions to
suppress COX2 expression, as both NP-nR and NP-R
clones show strong COX2 induction at 48 h of IL-1β treat-
ment in the absence of EGR1 (60,000 and 40,000 fold, re-
spectively). We previously reported that COX2 expression
correlates with hypertrophic differentiation in articular
cartilage models and pharmacological inhibition of COX2
decreases hypertrophy [29]. It is conceivable that COX2
induction, as part of a first line response, needs to be
avoided to prevent (irreversible) DDD. COX2 expression
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was specifically observed in degenerate discs [46] and a
correlation between DDD and cellular hypertrophy in the
NP has been observed before [30]. In line with this
thought: EGR1 was shown to be involved in repair of mes-
enchymal tissues [14, 15, 47]. It is of considerable interest
to establish whether and when a hypertrophic response is
initiated by these NP-nR cells and whether this is con-
nected to loss of EGR1. A similar rational may be envi-
sioned pertaining to keeping TNFα induction in check: this
would prevent full blown release of COX2, MMP13,
ADAMTS5 and Syndecan4 [48]. Despite the observed ef-
fects of EGR1 knock-down on transcriptional responses in
NP cells, this data does not provide evidence for direct pro-
moter binding of EGR1. Chromatin-immunoprecipitation
analysis of EGR1-binding and specific histone modifications
at these loci, as a function of response time, would shed
additional light on their exact role in respect to the ob-
served transcriptional response profiles.
Relevance EGR1 signaling in vivo
Classical genetic knock-out mice for EGR1 show no
overt phenotype associated with bone and/or cartilage
development, likely due to activation of functionally re-
dundant mechanisms (e.g. EGR2-4) in vivo that compen-
sate for loss of EGR1 function during development.
When models of acute plasticity are interrogated how-
ever, EGR1 function becomes clear in vivo and in vitro.
Following these strategies, it was established that EGR1
is important for adipogenesis and tenogenesis [13–15].
EGR1 (NGFI1, KROX24) and family members also me-
diate gene-environment interaction in the brain and is
responsible for i.a. dendritic spine formation and synap-
tic plasticity and controls higher brain functions includ-
ing movement, emotions, learning and memory [49–53].
Of relevance to the current study, EGR1 and EGR2 have
been associated with inflammatory responses at multiple
levels [17–20, 54]. We find that EGR1 is responsible for
anabolic and catabolic responses of distinct NP cell
types. EGR1 was shown to inhibit ECM molecule pro-
duction in chondrocytes exposed to TNFα [27]. We and
others have also shown that EGR1 is required for tissue
development and repair [16, 21, 22]. Combined, these
observations stress the importance of IEGs in general
and of EGR1 in particular in plastic biological systems.
Identification of downstream signaling components
within cell type-specific EGR1-dependent response path-
ways is expected to contribute to developing therapeutic
strategies for e.g. degenerative disc disease.
Conclusion
EGR1 functions at the cross roads of inflammation and
repair and represents an important response factor that
allows NP cells to adapt to anabolic or catabolic stimuli.
Well-defined cell models like the ones described herein
will be imperative to study the role of specific cellular
subtypes in degenerative disc disease and their potential
use in cell-based disc regeneration strategies.
Additional file
Additional file 1: Figure S1. Optimization of EGR1 knock-down using
siRNA, A) cells were transfected with the indicated concentrations of
siRNA against EGR1 mRNA (3, 30 and 100 nM). 30 nM and 100 nM
showed significant (*; p < 0.05) reduction of EGR1 expression compared
to siCTRL. B) Absence of off-target effects in siEGR1 treated cells. ERG1,
EGR2 and EGR3 mRNA levels are depicted in siCTRL- and in siEGR1-treated
cells. Only EGR1 mRNA levels were significantly reduced (*; p < 0.05). C)
Sustained EGR1 knock-down: NP-nR (nR) and NP-R (R) cells were stimulated
with ITS medium in the presence of control (CTRL; 30 nM) or EGR1 siRNA
(EGR1; 30 nM); EGR1 protein expression was measured at 0, 2 and 48 hours
post- stimulation in both cell lines. Βeta Actin (βACT) was used as loading
control; the indication (t+) points to a relatively long apposition time.
(TIF 59 kb)
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